SANTA CRUZ, Calif., July 11, 2017 /PRNewswire/ -- Dovetail Genomics™ LLC, which offers accurate and highly contiguous genome assemblies to researchers and clinicians, today announced that it has entered into a distribution agreement with Tree Code, a leading genomics-focused solutions provider based in Singapore and Malaysia, to bring Dovetail's genome assembly services to markets across Southeast Asia. The agreement gives Tree Code the ability to market and distribute Dovetail's genome assembly services to researchers in Singapore, Malaysia, Thailand, Vietnam, Indonesia, the Philippines and Myanmar.
"Tree Code is recognized as the regional expert in the genomics market and is known for providing superior customer support," said Veronica Mankinen, Vice President of Commercial Operations, Dovetail Genomics. "And Dovetail is known for delivering the highest quality genome assemblies available, making this a natural partnership. We are very excited to continue the expansion of our team in Asia and particularly excited to be working with Tree Code."
"Dovetail's proprietary proximity ligation and scaffolding technologies give an unparalleled competitive advantage to genomic researchers," said Dr. Sam Mohan, Business Director for Tree Code Group. "Its solution has been proven to deliver chromosomal level scaffolding while boosting contiguity and improving assembly accuracy – it even works for polyploidy genome projects.
"Dovetail's offering is conveniently provided as a service at very affordable cost. It needs no capital equipment investment which means that all genome projects have easy access to their innovative technology," Dr. Mohan said.
Dovetail offers a la carte genome assembly services for plant, animal and microbial genomes. Customers can choose from a number of options for genome assembly including full de novo assembly (with Illumina or PacBio sequencing methods) or assembly improvement.
About Dovetail Genomics
Dovetail Genomics LLC is transforming genomics by making long-range information readily accessible to all. The company enables researchers and clinicians to solve complex problems involving de novo assembly, structural variation, microbiome analysis, cancer research, phasing analysis and more by providing them a more comprehensive view of the genome. Its proprietary in vitro proximity ligation approach and assembly algorithms simplify genomic discovery by integrating the highest quality long-range genomic information with next-gen sequencing output. Dovetail is based in Santa Cruz, California. For more information on Dovetail, its technology, and service offerings, visit dovetailgenomics.com. Follow Dovetail on Twitter @DTGenomics.
SOURCE Dovetail Genomics LLC